TLR2 inhibition reprograms the tumor microenvironment and delays progression of recurrent ovarian cancer in vivoA. Alvero,M. Pitruzzello,B. Keogh,P. Mcguirk,M. Reilly, G. MorEUROPEAN JOURNAL OF CANCER(2018)引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要